Minulet

Minulet

A brand name for ETHINYLOESTRADIOL (ethinylestradiol) formulated with the PROGESTOGEN drug GESTODENE as an oral contraceptive.
References in periodicals archive ?
There was concern over "third generation" pills such as Femodene, Triadene, Minulet, Tri-minulet, Marvelon and Mercilon a few years ago but doctors have agreed since that the risk of DVT while on the Pill is actually much lower than the risk of getting a clot while pregnant.
The case centred on Marvelon, Mercilon, Minulet and Femodene pills.
The claims are against Schering Healthcare, manufacturer of Femodene; Wyeth, the maker of Minulet and Tri-Minulet; and Organon Laboratories, which manufactures Marvelon and Mercilon.
The litigation, including claims brought on behalf of women who have died, will focus on seven individual cases and involves the pills Femodene, Minulet and Tri-Minulet, Marvelon and Mercilon.
Wyeth is involved through its production of Minulet in 1988 and Tri-Minulet in 1992, while Organon Laboratories faces claims over its products of Marvelon, in 1981, and Mercilon, in 1989.
Schering brought out Femodene in 1987 and Wyeth marketed Minulet in 1988 and Tri-Minulet four years later.
Another company Wyeth is involved through its production of Minulet in 1988 and Tri-Minulet in 1992, while Organon Laboratories faces claims over its products of Marvelon, in 1981, and Mercilon, in 1989.
The pills - Femodene by Schering Healthcare, Minulet and Tri-Minulet by Wyeth and Marvelon and Mercilon by Organon - were all introduced in the 1980s or early 1990s.
Wyeth is involved through its production of Minulet in 1988 and TriMinulet in 1992, while Organon Laboratories faces claims over its products of Marvelon, in 1981, and Mercilon, in 1989.
The brands involved are Mercilon, Marvelon, Femodene, Femodette, Minulet and Triadene.
The companies involved are Wyeth of Maidenhead, Berks, makers of Minulet and Tri-Minulet; Schering Health Care Ltd, which makes Femodene; and Organon Laboratories Ltd, which makes Mercilon and Marvelon.
The scare in 1995 followed the discovery that seven types of Pill (Mercilon, Marvelon, Femodene, Femodene ED, Minulet, Triminulet and Triadene) were more likely to cause dangerous clots in women who took them.